Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Zhongxin Pharmaceutical Co., Ltd. is a specialized pharmaceutical manufacturing company based in Beijing, China, and operates as a key subsidiary of the Tianjin Pharmaceutical Da Ren Tang Group (formerly Tianjin Zhongxin Pharmaceutical Group). The company focuses on the research, development, and production of Traditional Chinese Medicines (TCM) and modern chemical drug formulations. Its core therapeutic focus areas include cardiovascular health, respiratory ailments, and gastrointestinal disorders, with a product portfolio featuring well-known treatments such as Compound Danshen tablets. Beijing Zhongxin Pharmaceutical operates GMP-certified facilities and leverages the extensive distribution network and R&D resources of its parent group to serve the domestic Chinese market. The company plays a significant role in the regional pharmaceutical supply chain, providing high-quality essential medicines to healthcare providers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Zhongxin Pharmaceutical.